Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04682483 · ClinicalTrials.gov registry record
Cardiogenic Shock Working Group Registry
A clinical trial of Cardiogenic Shock, sponsored by Tufts Medical Center.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 16
- Study locations
NCT04682483: Recruiting study of Cardiogenic Shock, sponsored by Tufts Medical Center.
NCT04682483 is a study of Cardiogenic Shock that is actively recruiting participants, run by Tufts Medical Center. The registered enrollment target is 5,000 participants, above the 322-participant average among 16 other Cardiogenic Shock trials with a reported enrollment target (1453% higher). The trial reports 16 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04682483, a study of Cardiogenic Shock, is actively recruiting participants, sponsored by Tufts Medical Center.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 16
- Study locations
Study Summary
The Cardiogenic Shock Working Group is a multicenter registry where we collect de-identified clinical variables from the medical records and follow-up phone calls of shock patients from multiple institutions and centralize this data to a single registry for analysis of clinical outcomes.
Primary Outcome
Death in subjects during the time frame.
Conditions Studied
Interventions
- DRUG Vasopressor
- DRUG Inotrope
- DEVICE Acute Mechanical Circulatory Support Devices
Study Locations (16)
Texas
- Baylor Scott & White Advanced Heart Failure Clinic - Dallas
- University of Texas Medical Branch - Galveston
- Houston Methodist Hospital - Houston
Illinois
- Northwestern Medicine - Chicago
- University of Chicago - Chicago
Massachusetts
- Tufts Medical Center - Boston
- Beth Israel Deaconess Medical Center - Boston
Pennsylvania
- Allegheny General Hospital - Pittsburgh
- University Of Pittsburgh Medical Center - Pittsburgh
Florida
- Cleveland Clinic Florida - Weston
Maine
- Maine Medical Center - Portland
New Jersey
- Hackensack Meridian Health - Hackensack
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2017-12-04 |
| Est. Completion | 2026-06-01 |
What NCT04682483 shows while recruiting
NCT04682483 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 322-participant average among 16 other Cardiogenic Shock trials with a reported enrollment target (1453% higher).
The record links to 1 condition, with Cardiogenic Shock appearing as the primary indexed condition, and to 3 interventions - of which Vasopressor is the first listed.
NCT04682483 lists 16 locations in 11 states (Texas, Illinois, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT04682483 about?
NCT04682483 is a clinical study titled "Cardiogenic Shock Working Group Registry". The Cardiogenic Shock Working Group is a multicenter registry where we collect de-identified clinical variables from the medical records and follow-up phone calls of shock patients from multiple institutions and centralize this data to a single registry for analysis of clinical outcomes.
What is the current status of trial NCT04682483?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2017-12-04. Estimated completion is 2026-06-01.
What conditions does trial NCT04682483 study?
This clinical trial studies the following conditions: Cardiogenic Shock.
What interventions are being tested in trial NCT04682483?
The interventions under investigation include: Vasopressor (DRUG), Inotrope (DRUG), Acute Mechanical Circulatory Support Devices (DEVICE).
Who is sponsoring clinical trial NCT04682483?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04682483 being conducted?
This trial has 16 study locations across Florida, Illinois, Maine, Massachusetts, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiogenic Shock
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04682483's enrollment target sits among peer trials
5,000 1st of 16 higher than 16 of 16 other Cardiogenic Shock trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiogenic Shock trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Cardiac Power Output in Cardiogenic Shock Patients
RECRUITING · Early Phase 1
-
Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure
RECRUITING
-
Inova Cardiogenic Shock Registry (INOVA SHOCK)
RECRUITING
-
Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR
RECRUITING
-
Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI